Piirre
Nausea and vomiting
Nausea is a commonly encountered symptom that has been defined as an unpleasant painless subjective feeling that one will imminently vomit. Vomiting has been defined as the forceful expulsion of the contents of the stomach, duodenum, or jejunum through the oral cavity. While nausea and vomiting are often thought to exist on a temporal continuum, this is not always the case. There are situations when severe nausea may be present without emesis and less frequently, when emesis may be present without preceding nausea.
Yhteenveto
- Elimistön järjestelmä
- Abnormality of the digestive system
Read the genes linked to Nausea and vomiting, and the rest of your genome, with one test.
Alkaen 449 $Ilmainen toimitus · Tulokset 6–8 viikossa
Tilaa Genome Test153 geeniä, jotka liittyvät piirteeseen Nausea and vomiting
Näiden geenien muutokset aiheuttavat harvinaisia sairauksia, joissa Nausea and vomiting esiintyy. Useimmilla, joilla on tämä piirre, ei ole mitään näistä sairauksista, eikä tämän listan geeni kerro mitään kenenkään omasta genomista.
| Geeni | Kuinka usein sitä esiintyy | Sairaudet |
|---|---|---|
| ATP9AATPase phospholipid transporting 9A | Aina | 1 sairaudessa |
| NOTCH3notch receptor 3 | Aina | 1 sairaudessa |
| SLC25A4solute carrier family 25 member 4 | Aina | 1 sairaudessa |
| ABCD1ATP binding cassette subfamily D member 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| ACTG2actin gamma 2, smooth muscle | Hyvin usein (80–99%) | 1 sairaudessa |
| ATP7AATPase copper transporting alpha | Hyvin usein (80–99%) | 2 sairaudessa |
| BCL10BCL10 immune signaling adaptor | Hyvin usein (80–99%) | 1 sairaudessa |
| BIRC3baculoviral IAP repeat containing 3 | Hyvin usein (80–99%) | 1 sairaudessa |
| BRCA1BRCA1 DNA repair associated | Hyvin usein (80–99%) | 2 sairaudessa |
| C4Acomplement C4A (Chido/Rodgers blood group) | Hyvin usein (80–99%) | 1 sairaudessa |
| CCR1C-C motif chemokine receptor 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| ECE1endothelin converting enzyme 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| EDN3endothelin 3 | Hyvin usein (80–99%) | 1 sairaudessa |
| EDNRBendothelin receptor type B | Hyvin usein (80–99%) | 1 sairaudessa |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Hyvin usein (80–99%) | 2 sairaudessa |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Hyvin usein (80–99%) | 1 sairaudessa |
| FASFas cell surface death receptor | Hyvin usein (80–99%) | 1 sairaudessa |
| FOXP1forkhead box P1 | Hyvin usein (80–99%) | 1 sairaudessa |
| FSHRfollicle stimulating hormone receptor | Hyvin usein (80–99%) | 1 sairaudessa |
| GDNFglial cell derived neurotrophic factor | Hyvin usein (80–99%) | 1 sairaudessa |
| HLA-Bmajor histocompatibility complex, class I, B | Hyvin usein (80–99%) | 2 sairaudessa |
| HLCSholocarboxylase synthetase | Hyvin usein (80–99%) | 1 sairaudessa |
| IFNGR1interferon gamma receptor 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| IGHimmunoglobulin heavy locus | Hyvin usein (80–99%) | 1 sairaudessa |
| IKZF1IKAROS family zinc finger 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| IL10interleukin 10 | Hyvin usein (80–99%) | 1 sairaudessa |
| IL12Ainterleukin 12A | Hyvin usein (80–99%) | 1 sairaudessa |
| IL12A-AS1IL12A antisense RNA 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| IL23Rinterleukin 23 receptor | Hyvin usein (80–99%) | 1 sairaudessa |
| ITGA6integrin subunit alpha 6 | Hyvin usein (80–99%) | 1 sairaudessa |
| ITGB4integrin subunit beta 4 | Hyvin usein (80–99%) | 1 sairaudessa |
| KLRC4killer cell lectin like receptor C4 | Hyvin usein (80–99%) | 1 sairaudessa |
| LIPAlipase A, lysosomal acid type | Hyvin usein (80–99%) | 2 sairaudessa |
| LMOD1leiomodin 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| MALT1MALT1 paracaspase | Hyvin usein (80–99%) | 1 sairaudessa |
| MEFVMEFV innate immunity regulator, pyrin | Hyvin usein (80–99%) | 2 sairaudessa |
| MMUTmethylmalonyl-CoA mutase | Hyvin usein (80–99%) | 2 sairaudessa |
| MYH11myosin heavy chain 11 | Hyvin usein (80–99%) | 1 sairaudessa |
| MYLKmyosin light chain kinase | Hyvin usein (80–99%) | 1 sairaudessa |
Näytä 113 geeniä lisää
| Geeni | Kuinka usein sitä esiintyy | Sairaudet |
|---|---|---|
| NLRP3NLR family pyrin domain containing 3 | Hyvin usein (80–99%) | 2 sairaudessa |
| NRTNneurturin | Hyvin usein (80–99%) | 1 sairaudessa |
| PTENphosphatase and tensin homolog | Hyvin usein (80–99%) | 1 sairaudessa |
| RETret proto-oncogene | Hyvin usein (80–99%) | 1 sairaudessa |
| RHBDF2rhomboid 5 homolog 2 | Hyvin usein (80–99%) | 1 sairaudessa |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Hyvin usein (80–99%) | 2 sairaudessa |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Hyvin usein (80–99%) | 2 sairaudessa |
| SDHCsuccinate dehydrogenase complex subunit C | Hyvin usein (80–99%) | 2 sairaudessa |
| SEMA3Csemaphorin 3C | Hyvin usein (80–99%) | 1 sairaudessa |
| SEMA3Dsemaphorin 3D | Hyvin usein (80–99%) | 1 sairaudessa |
| SLC1A3solute carrier family 1 member 3 | Hyvin usein (80–99%) | 1 sairaudessa |
| SLC46A1solute carrier family 46 member 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Hyvin usein (80–99%) | 2 sairaudessa |
| SMOsmoothened, frizzled class receptor | Hyvin usein (80–99%) | 2 sairaudessa |
| SREBF1sterol regulatory element binding transcription factor 1 | Hyvin usein (80–99%) | 1 sairaudessa |
| STAT4signal transducer and activator of transcription 4 | Hyvin usein (80–99%) | 1 sairaudessa |
| TLR4toll like receptor 4 | Hyvin usein (80–99%) | 1 sairaudessa |
| UBAC2UBA domain containing 2 | Hyvin usein (80–99%) | 1 sairaudessa |
| AIPAHR interacting HSP90 co-chaperone | Usein (30–79%) | 1 sairaudessa |
| AKT1AKT serine/threonine kinase 1 | Usein (30–79%) | 1 sairaudessa |
| AQP2aquaporin 2 | Usein (30–79%) | 1 sairaudessa |
| ATMATM serine/threonine kinase | Usein (30–79%) | 1 sairaudessa |
| ATRXATRX chromatin remodeler | Usein (30–79%) | 2 sairaudessa |
| AVPR2arginine vasopressin receptor 2 | Usein (30–79%) | 1 sairaudessa |
| BAP1BRCA1 associated deubiquitinase 1 | Usein (30–79%) | 1 sairaudessa |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Usein (30–79%) | 1 sairaudessa |
| BMPR1Abone morphogenetic protein receptor type 1A | Usein (30–79%) | 1 sairaudessa |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Usein (30–79%) | 1 sairaudessa |
| BRCA2BRCA2 DNA repair associated | Usein (30–79%) | 2 sairaudessa |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Usein (30–79%) | 1 sairaudessa |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Usein (30–79%) | 2 sairaudessa |
| CAV1caveolin 1 | Usein (30–79%) | 2 sairaudessa |
| CCN2cellular communication network factor 2 | Usein (30–79%) | 2 sairaudessa |
| CCR6C-C motif chemokine receptor 6 | Usein (30–79%) | 2 sairaudessa |
| CDH23cadherin related 23 | Usein (30–79%) | 2 sairaudessa |
| CHEK2checkpoint kinase 2 | Usein (30–79%) | 1 sairaudessa |
| CLIP2CAP-Gly domain containing linker protein 2 | Usein (30–79%) | 1 sairaudessa |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Usein (30–79%) | 1 sairaudessa |
| CTNNB1catenin beta 1 | Usein (30–79%) | 1 sairaudessa |
| DLEC1DLEC1 cilia and flagella associated protein | Usein (30–79%) | 1 sairaudessa |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Usein (30–79%) | 1 sairaudessa |
| DNASE1L3deoxyribonuclease 1L3 | Usein (30–79%) | 1 sairaudessa |
| EIF4Heukaryotic translation initiation factor 4H | Usein (30–79%) | 1 sairaudessa |
| ELNelastin | Usein (30–79%) | 1 sairaudessa |
| EPCAMepithelial cell adhesion molecule | Usein (30–79%) | 1 sairaudessa |
| EWSR1EWS RNA binding protein 1 | Usein (30–79%) | 1 sairaudessa |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Usein (30–79%) | 1 sairaudessa |
| GATA2GATA binding protein 2 | Usein (30–79%) | 1 sairaudessa |
| GLAgalactosidase alpha | Usein (30–79%) | 1 sairaudessa |
| GTF2Igeneral transcription factor IIi | Usein (30–79%) | 1 sairaudessa |
| GTF2IRD1GTF2I repeat domain containing 1 | Usein (30–79%) | 1 sairaudessa |
| GTF2IRD2GTF2I repeat domain containing 2 | Usein (30–79%) | 1 sairaudessa |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Usein (30–79%) | 1 sairaudessa |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Usein (30–79%) | 1 sairaudessa |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Usein (30–79%) | 2 sairaudessa |
| HMBShydroxymethylbilane synthase | Usein (30–79%) | 1 sairaudessa |
| IRF5interferon regulatory factor 5 | Usein (30–79%) | 2 sairaudessa |
| KIAA0319LKIAA0319 like | Usein (30–79%) | 1 sairaudessa |
| KITKIT proto-oncogene, receptor tyrosine kinase | Usein (30–79%) | 1 sairaudessa |
| KRASKRas proto-oncogene, GTPase | Usein (30–79%) | 2 sairaudessa |
| LIMK1LIM domain kinase 1 | Usein (30–79%) | 1 sairaudessa |
| MEN1menin 1 | Usein (30–79%) | 1 sairaudessa |
| METTL27methyltransferase like 27 | Usein (30–79%) | 1 sairaudessa |
| MLH1mutL homolog 1 | Usein (30–79%) | 1 sairaudessa |
| MSH2mutS homolog 2 | Usein (30–79%) | 1 sairaudessa |
| MSH6mutS homolog 6 | Usein (30–79%) | 1 sairaudessa |
| MUTYHmutY DNA glycosylase | Usein (30–79%) | 1 sairaudessa |
| NCF1neutrophil cytosolic factor 1 | Usein (30–79%) | 1 sairaudessa |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Usein (30–79%) | 1 sairaudessa |
| NPATnuclear protein, coactivator of histone transcription | Usein (30–79%) | 1 sairaudessa |
| PDGFBplatelet derived growth factor subunit B | Usein (30–79%) | 1 sairaudessa |
| PDGFRAplatelet derived growth factor receptor alpha | Usein (30–79%) | 1 sairaudessa |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Usein (30–79%) | 2 sairaudessa |
| PMS1PMS1 homolog 1, mismatch repair system component | Usein (30–79%) | 1 sairaudessa |
| PMS2PMS1 homolog 2, mismatch repair system component | Usein (30–79%) | 1 sairaudessa |
| POLD1DNA polymerase delta 1, catalytic subunit | Usein (30–79%) | 1 sairaudessa |
| POLEDNA polymerase epsilon, catalytic subunit | Usein (30–79%) | 1 sairaudessa |
| PRTN3proteinase 3 | Usein (30–79%) | 1 sairaudessa |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Usein (30–79%) | 1 sairaudessa |
| RFC2replication factor C subunit 2 | Usein (30–79%) | 1 sairaudessa |
| RNF6ring finger protein 6 | Usein (30–79%) | 1 sairaudessa |
| RPS20ribosomal protein S20 | Usein (30–79%) | 1 sairaudessa |
| SEMA4Asemaphorin 4A | Usein (30–79%) | 1 sairaudessa |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Usein (30–79%) | 1 sairaudessa |
| STX1Asyntaxin 1A | Usein (30–79%) | 1 sairaudessa |
| SUFUSUFU negative regulator of hedgehog signaling | Usein (30–79%) | 1 sairaudessa |
| TBK1TANK binding kinase 1 | Usein (30–79%) | 1 sairaudessa |
| TBL2transducin beta like 2 | Usein (30–79%) | 1 sairaudessa |
| TERTtelomerase reverse transcriptase | Usein (30–79%) | 1 sairaudessa |
| TGFBR2transforming growth factor beta receptor 2 | Usein (30–79%) | 2 sairaudessa |
| TICAM1TIR domain containing adaptor molecule 1 | Usein (30–79%) | 1 sairaudessa |
| TLR3toll like receptor 3 | Usein (30–79%) | 1 sairaudessa |
| TMEM270transmembrane protein 270 | Usein (30–79%) | 1 sairaudessa |
| TRAF3TNF receptor associated factor 3 | Usein (30–79%) | 1 sairaudessa |
| TRAF7TNF receptor associated factor 7 | Usein (30–79%) | 1 sairaudessa |
| TRMT5tRNA methyltransferase 5 | Usein (30–79%) | 1 sairaudessa |
| UNC93B1unc-93B1 regulator of TLR signaling | Usein (30–79%) | 1 sairaudessa |
| VPS37DVPS37D subunit of ESCRT-I | Usein (30–79%) | 1 sairaudessa |
| WT1WT1 transcription factor | Usein (30–79%) | 1 sairaudessa |
| WWOXWW domain containing oxidoreductase | Usein (30–79%) | 1 sairaudessa |
| CDC73cell division cycle 73 | Joskus (5–29%) | 2 sairaudessa |
| CDKN2Acyclin dependent kinase inhibitor 2A | Joskus (5–29%) | 1 sairaudessa |
| CLCNKBchloride voltage-gated channel Kb | Joskus (5–29%) | 1 sairaudessa |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Joskus (5–29%) | 1 sairaudessa |
| MYCMYC proto-oncogene, bHLH transcription factor | Joskus (5–29%) | 1 sairaudessa |
| PALB2partner and localizer of BRCA2 | Joskus (5–29%) | 1 sairaudessa |
| PALLDpalladin, cytoskeletal associated protein | Joskus (5–29%) | 1 sairaudessa |
| RAB27ARAB27A, member RAS oncogene family | Joskus (5–29%) | 1 sairaudessa |
| RABL3RAB, member of RAS oncogene family like 3 | Joskus (5–29%) | 1 sairaudessa |
| SDHDsuccinate dehydrogenase complex subunit D | Joskus (5–29%) | 1 sairaudessa |
| SLC12A3solute carrier family 12 member 3 | Joskus (5–29%) | 1 sairaudessa |
| SMAD4SMAD family member 4 | Joskus (5–29%) | 1 sairaudessa |
| TP53tumor protein p53 | Joskus (5–29%) | 1 sairaudessa |
Kuinka usein ilmiö esiintyy ihmisillä, joilla on jokin geenin sairauksista, niin kuin Human Phenotype Ontology sen kirjaa. Nämä sivut kuvaavat piirteitä ja niiden taustalla olevaa tutkimusta, eivätkä ne ole diagnoosi. Oireista kannattaa kysyä lääkäriltä tai geneettiseltä neuvojalta.
Tarkemmat piirteet
Laajemmat piirteet
Mistä tämä tieto tulee
- Human Phenotype Ontology, julkaisu 2026-09-01: piirre, sen nimet, määritelmä ja siihen liitetyt geenit. Lue lisää osoitteesta hpo.jax.org.
- Tietojulkaisu 2026.10.16-c6eea6bf.
Yksi testi. Vastauksia koko elämäksi.
Alkaen 449 $Ilmainen toimitus · Tulokset 6–8 viikossa